THELPER AS
Developing innovative antiviral antibody drug conjugates for aggressive solid tumors.
Overview
- Unknown
- Employees
- 5.8M NOK
- Revenue
- 2019
- Founded
Key Decision Makers
Katja Vetvik
Founder and CEO
Description
Thelper AS is a Norwegian biotechnology company focused on developing innovative treatments for incurable cancers. They specialize in first-in-class antiviral antibody drug conjugates that target virally encoded biomarkers found in aggressive solid tumors. By identifying markers absent in healthy ti...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
1 contacts in FunnelfeedrKatja Vetvik
Founder and CEO
Similar Companies
20 similar companies in Funnelfeedr
ACTITHERA NORWAY AS
10 employeesDeveloping precision radioligand therapies to treat difficult cancer cases.
TILT Biotherapeutics Oy
Developing innovative oncolytic viral immunotherapies to treat solid tumors.
THERAMEX IRELAND LIMITED
0 employeesGlobal pharmaceutical company dedicated to advancing women's health and wellbeing.
THERMO FISHER SCIENTIFIC CHROMATOGRAPHY HOLDINGS ApS
Global leader providing innovative scientific technologies and laboratory research solutions.
PERBIO SCIENCE SWEDEN HOLDINGS AB
0 employeesGlobal leader providing innovative scientific technologies and laboratory research solutions.
Browse More
THELPER AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo